This clinical investigation will be conducted as a multicentre, open-label, randomised in parallel groups, controlled study on patients with infected venous leg ulcers.
During the screening, all patients will be assessed for inclusion and exclusion criteria and wound exudation status. Eligible patients with slight or moderate wound exudation will be randomly assigned to treatment with either Suprasorb®X+PHMB Pro or Suprasorb®X+PHMB. The patients who fulfil all other eligibility criteria but have high level of wound exudation will enter a 7-days run-in period, during which they will receive superabsorbent dressing (e.g. Vliwazell® Pro, Vliwasorb® Pro) and monitored compression therapy with Rosidal® 1C. During the run-in period they should receive appropriate treatment including systemic antimicrobial drug therapy if required. After this time, these patients should be re-assessed and in case they still fulfil all eligibility criteria, and the exudation decreased at least to a moderate level, they will be randomised to Suprasorb®X+PHMB Pro or Suprasorb®X+PHMB. In case the exudation would not decrease within this period or other eligibility criteria are not met anymore, they will be screened out. Upon randomisation, all patients will receive the assigned dressing for 21 (±2) days, or till the complete epithelialization, if it occurs earlier. The patients should also continue to receive adequate compression and, if necessary, systemic antimicrobial drug therapy. During the study participation, selected parameters of the wound will be assessed at Baseline, Interim Visit, and EOT visit. In addition, dressing changes may be performed in-between on as needed basis. After 3 weeks of treatment with Suprasorb®X+PHMB Pro or Suprasorb®X+PHMB, all patients will complete the study. Their further treatment (if necessary), will not be the part of the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
150
Application of a wound dressing with additional polyethylene film on top and compression therapy. Optional usage of the systemic antimicrobial therapy.
Application of a wound dressing without additional polyethylene film on top and compression therapy. Optional usage of the systemic antimicrobial therapy.
Centrum Medyczne Ultramed
Krakow, Poland
NOT_YET_RECRUITINGMelissaMed Poradnia Chirurgiczna
Lodz, Poland
NOT_YET_RECRUITINGMikomed Spółka Z Ograniczoną Odpowiedzialnością
Lodz, Poland
Rate and severity of maceration after 3 weeks of treatment with Suprasorb®X+PHMB (Pro)
on a 4-grade scale there 0 means no maceration and 4 means severe maceration
Time frame: 3 weeks
Wound area change over time
in mm2
Time frame: 3 weeks
Change of necrotic & fibrinous & granulation tissue rate in the wound bed
in %
Time frame: 3 weeks
Change of wound infection status
by a TILI (Therapeutical Index for Local Infections) score with a range 1-6. TILI \< 5 indicates a wound without infection, whereas TILI ≥ 5 means a local wound infection.
Time frame: 3 weeks
Product safety (rate of product-related complications)
by rate of product-related complications
Time frame: 3 weeks
Change of wound exudation and presence of peri-wound oedema
by the investigators' assessment of exudation grade
Time frame: 3 weeks
Change in patient's pain
By NRS (numeric rating scale), with zero meaning "no pain" and 10 meaning "the worst pain imaginable"
Time frame: 3 weeks
Product usability
by user and patient questionnaire
Time frame: 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Niepubliczny Zakład Opieki Zdrowotnej "Argo" Centrum Medyczne
Lodz, Poland
NOT_YET_RECRUITINGPP CLINIC Pietrzyk spółka partnerska lekarzy
Lublin, Poland
NOT_YET_RECRUITINGSPECJALISTYCZNY OSRODEK LECZNICZO BADAWCZY, Zbigniew Żęgota
Ostróda, Poland
NOT_YET_RECRUITINGLecran - Centrum Opieki Nad Ranami-Kunickiego
Wroclaw, Poland
NOT_YET_RECRUITINGSpecjalistyczna Pomoc Medyczna "Medservice"
Zabrze, Poland
NOT_YET_RECRUITINGChange in patient's quality of life
by Wound QoL-17 (wound quality of life) questionnaire
Time frame: 3 weeks
Oedema chamge
by measurement of limb circumference
Time frame: 3 weeks
Sub-bandage pressure levels retention
difference of the pressure levels, measured at the time of application and before the next dressing change with a wireless sensor
Time frame: 3 weeks